Jim Simons Altimmune, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$2.4 - $3.45 $786,720 - $1.13 Million	-327,800 Reduced 49.76%	330,900 $860,000
Q2 2023 Aug 11, 2023	BUY	$3.45 - $5.97 $1.32 Million - $2.28 Million	382,400 Added 138.4%	658,700 $2.33 Million
Q1 2023 May 12, 2023	SELL	$4.19 - $16.83 $970,823 - $3.9 Million	-231,700 Reduced 45.61%	276,300 $1.17 Million
Q4 2022 Feb 13, 2023	SELL	$8.74 - $16.45 $4.28 Million - $8.06 Million	-490,200 Reduced 49.11%	508,000 $8.36 Million
Q3 2022 Nov 14, 2022	BUY	$10.67 - $22.41 $3.55 Million - $7.46 Million	332,800 Added 50.02%	998,200 $12.7 Million
Q2 2022 Aug 12, 2022	BUY	$3.94 - $11.77 $1.09 Million - $3.26 Million	276,700 Added 71.19%	665,400 $7.79 Million
Q1 2022 May 13, 2022	BUY	$5.9 - $9.45 $1.9 Million - $3.04 Million	321,900 Added 481.89%	388,700 $2.37 Million
Q4 2021 Feb 11, 2022	BUY	$8.69 - $12.48 $580,492 - $833,664	66,800 New	66,800 $612,000
Q4 2020 Feb 10, 2021	SELL	$7.84 - $14.22 $8.03 Million - $14.6 Million	-1,024,507 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$9.93 - $33.26 $981,084 - $3.29 Million	98,800 Added 10.67%	1,024,507 $13.5 Million
Q2 2020 Aug 13, 2020	BUY	$2.9 - $10.71 $895,230 - $3.31 Million	308,700 Added 50.03%	925,707 $9.91 Million
Q1 2020 May 14, 2020	BUY	$1.69 - $3.8 $749,778 - $1.69 Million	443,656 Added 255.93%	617,007 $1.98 Million
Q4 2019 Feb 13, 2020	BUY	$1.53 - $2.15 $198,496 - $278,932	129,736 Added 297.46%	173,351 $328,000
Q3 2019 Nov 13, 2019	BUY	$1.95 - $2.66 $85,049 - $116,015	43,615 New	43,615 $85,000
Q2 2019 Aug 12, 2019	SELL	$2.19 - $3.4 $239,380 - $371,640	-109,306 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$2.54 - $4.54 $216,408 - $386,808	-85,200 Reduced 43.8%	109,306 $317,000
Q4 2018 Feb 13, 2019	BUY	$1.72 - $7.24 $334,550 - $1.41 Million	194,506 New	194,506 $401,000

Others Institutions Holding ALT

# of Institutions

186

Shares Held

39.3M

Call Options Held

913K

Put Options Held

743K

Black Rock Inc. New York, NY

5.32M
Shares

$43.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.98M
Shares

$41.1 Million
0.0% of portfolio
Ameriprise Financial Inc Minneapolis, MN

3.88M
Shares

$32 Million
0.01% of portfolio
State Street Corp Boston, MA

3.41M
Shares

$28.2 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.75M
Shares

$22.7 Million
1.44% of portfolio

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $404M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account